Scarica l'app Stockscreener
2.695
2.00%
-0.055
Precedente Chiudi:
$2.75
Aprire:
$2.7
Volume 24 ore:
33,051
Relative Volume:
0.41
Capitalizzazione di mercato:
$34.55M
Reddito:
-
Utile/perdita netta:
$-70.20M
Rapporto P/E:
-0.0601
EPS:
-44.82
Flusso di cassa netto:
$-50.66M
1 W Prestazione:
+3.65%
1M Prestazione:
-2.00%
6M Prestazione:
-36.74%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$2.68
$2.80
Intervallo di 1 settimana:
$2.445
$2.85
Portata 52W:
$1.70
$19.40
Onkure Therapeutics Inc Stock (OKUR) Company Profile
Nome
Onkure Therapeutics Inc
Settore
Industria
Telefono
(720) 307-2892
Indirizzo
6707 WINCHESTER CIRCLE, SUITE 400, BOULDER
Confronta OKUR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OKUR
Onkure Therapeutics Inc
|
2.69 | 37.21M | 0 | -70.20M | -50.66M | -44.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
404.40 | 100.41B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
606.41 | 59.59B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
463.33 | 59.77B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
773.20 | 45.14B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
342.96 | 37.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Onkure Therapeutics Inc Stock (OKUR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-04-30 | Iniziato | Evercore ISI | Outperform |
| 2024-12-05 | Iniziato | Leerink Partners | Outperform |
| 2024-10-10 | Iniziato | Oppenheimer | Outperform |
| 2023-12-15 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2023-12-15 | Downgrade | Jefferies | Buy → Hold |
| 2023-12-15 | Downgrade | Leerink Partners | Outperform → Market Perform |
| 2023-12-14 | Downgrade | BofA Securities | Buy → Underperform |
| 2023-12-14 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2023-12-14 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-12-14 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2023-12-14 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2023-11-15 | Iniziato | William Blair | Outperform |
| 2023-08-28 | Iniziato | H.C. Wainwright | Buy |
| 2023-07-03 | Iniziato | BofA Securities | Buy |
| 2022-09-19 | Ripresa | H.C. Wainwright | Buy |
| 2022-01-27 | Iniziato | Robert W. Baird | Outperform |
| 2021-12-21 | Iniziato | H.C. Wainwright | Buy |
| 2021-11-22 | Iniziato | Ladenburg Thalmann | Buy |
| 2021-05-04 | Iniziato | Jefferies | Buy |
| 2021-05-04 | Iniziato | Piper Sandler | Overweight |
| 2021-05-04 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Onkure Therapeutics Inc Borsa (OKUR) Ultime notizie
Relative strength of OnKure Therapeutics Inc. in sector analysisJuly 2025 Review & Reliable Price Breakout Alerts - newser.com
What data driven models say about OnKure Therapeutics Inc.’s futureMarket Growth Summary & High Accuracy Trade Signal Alerts - newser.com
Using Python tools to backtest OnKure Therapeutics Inc. strategiesJuly 2025 Technicals & Entry Point Strategy Guides - newser.com
OnKure Therapeutics Inc. stock volume spike explainedJuly 2025 Gainers & Expert Approved Momentum Trade Ideas - newser.com
Applying Wyckoff theory to OnKure Therapeutics Inc. stockWeekly Investment Recap & Fast Exit and Entry Strategy Plans - newser.com
Can trapped investors hope for a rebound in OnKure Therapeutics Inc.Gap Down & Weekly High Potential Alerts - newser.com
How OnKure Therapeutics Inc. stock trades before earningsWeekly Volume Report & Growth Focused Investment Plans - newser.com
What analysts say about OnKure Therapeutics Inc stockTrading Volume Surges & High Return Wealth Plans - earlytimes.in
What drives OnKure Therapeutics Inc stock priceGrowth vs. Value Investing & You’ve Never Seen Stock Picks Like These - earlytimes.in
Advanced analytics toolkit walkthrough for OnKure Therapeutics Inc.Portfolio Growth Summary & Stepwise Trade Execution Plans - newser.com
LifeSci Capital Maintains OnKure Therapeutics(OKUR.US) With Buy Rating, Raises Target Price to $21 - 富途牛牛
OnKure Therapeutics CEO Saccomano sells $230 in stock By Investing.com - Investing.com Australia
OnKure Therapeutics CEO Saccomano sells $230 in stock - Investing.com India
OKUR SEC FilingsOnKure Therapeutics 10-K, 10-Q, 8-K Forms - Stock Titan
Quantitative breakdown of OnKure Therapeutics Inc. recent movePortfolio Return Summary & AI Powered Trade Plan Recommendations - newser.com
Can OnKure Therapeutics Inc. recover in the next quarterJuly 2025 Outlook & Daily Entry Point Alerts - newser.com
Backtesting results for OnKure Therapeutics Inc. trading strategiesEarnings Overview Summary & Stock Portfolio Risk Management - newser.com
Does OnKure Therapeutics Inc have high return on assets2025 Trading Recap & Risk Controlled Stock Pick Alerts - khodrobank.com
Published on: 2025-09-20 08:05:52 - خودرو بانک
Detecting price anomalies in OnKure Therapeutics Inc. with AIPortfolio Gains Report & Weekly Stock Performance Updates - newser.com
Published on: 2025-09-20 05:11:15 - khodrobank.com
Onkure Therapeutics Inc Azioni (OKUR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.83%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):